As a healthcare professional working directly with patients, Jonathan "Gio" Stelly argues that Congress should delay the November 12 restrictions on hemp-derived THC beverages and instead pursue a regulatory framework grounded in science, consumer safety, and patient access.

The November 12 restrictions on hemp-derived THC beverages may have unintended consequences for public health. Amanda Parker argues that Congress should pursue responsible regulation focused on safety, consumer protection, and harm reduction rather than restricting access to products that many adults use as an alternative to alcohol.

Millions of Americans—including veterans, first responders, seniors, and trauma survivors—face barriers accessing treatments that may improve their quality of life because insurance coverage has not kept pace with scientific research. AACPN's Alternative Care Access Campaign advocates for Medicare, Medicaid, VA, and private insurance policies that incorporate evidence-based alternative and integrative healthcare treatments shown to be safe, effective, and beneficial to patien

AACPN is calling for expanded scientific research into psychedelic-assisted therapies as potential trauma treatment options for survivors of sexual violence. The organization says survivors deserve compassionate, evidence-based care and continued research into emerging mental health therapies including MDMA, psilocybin, and ketamine-assisted treatment.

The American Alternative Care Policy Network (AACPN) this week launched its Psychedelic Research Initiative to support continued scientific research into emerging therapies that may help address some of America's most difficult mental health challenges. At the center of this effort are veterans. For many veterans, the invisible wounds of service can persist long after they return home. Post-traumatic stress, depression, anxiety, traumatic brain injury, substance-use disorders

The American Alternative Care Policy Network has launched a new initiative opposing upcoming federal restrictions on hemp-derived THC beverages and advocating for responsible, science-based regulation focused on consumer safety, harm reduction, trauma recovery, and evidence-based alternative care policy.

The TSA’s updated guidance on medical marijuana travel marks a significant step toward more practical and patient-centered federal cannabis policy. AACPN examines what the change means for veterans, medical cannabis patients, and the future of domestic travel reform.